128 related articles for article (PubMed ID: 32227927)
1. Effect of HIV-1 TAT Peptide Fusion on 5' mRNA Cap Analogs Cell Membrane Permeability and Translation Inhibition.
Piecyk K; Pietrow P; Arnold T; Worch R; Korneeva NL; Jankowska-Anyszka M
Bioconjug Chem; 2020 Apr; 31(4):1156-1166. PubMed ID: 32227927
[TBL] [Abstract][Full Text] [Related]
2. High affinity RNA for mammalian initiation factor 4E interferes with mRNA-cap binding and inhibits translation.
Mochizuki K; Oguro A; Ohtsu T; Sonenberg N; Nakamura Y
RNA; 2005 Jan; 11(1):77-89. PubMed ID: 15611299
[TBL] [Abstract][Full Text] [Related]
3. Biophysical studies of eIF4E cap-binding protein: recognition of mRNA 5' cap structure and synthetic fragments of eIF4G and 4E-BP1 proteins.
Niedzwiecka A; Marcotrigiano J; Stepinski J; Jankowska-Anyszka M; Wyslouch-Cieszynska A; Dadlez M; Gingras AC; Mak P; Darzynkiewicz E; Sonenberg N; Burley SK; Stolarski R
J Mol Biol; 2002 Jun; 319(3):615-35. PubMed ID: 12054859
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of Mitogen-activated Protein Kinase (MAPK)-interacting Kinase (MNK) Preferentially Affects Translation of mRNAs Containing Both a 5'-Terminal Cap and Hairpin.
Korneeva NL; Song A; Gram H; Edens MA; Rhoads RE
J Biol Chem; 2016 Feb; 291(7):3455-67. PubMed ID: 26668315
[TBL] [Abstract][Full Text] [Related]
5. The antiviral drug ribavirin does not mimic the 7-methylguanosine moiety of the mRNA cap structure in vitro.
Westman B; Beeren L; Grudzien E; Stepinski J; Worch R; Zuberek J; Jemielity J; Stolarski R; Darzynkiewicz E; Rhoads RE; Preiss T
RNA; 2005 Oct; 11(10):1505-13. PubMed ID: 16131589
[TBL] [Abstract][Full Text] [Related]
6. Activity of the hepatitis A virus IRES requires association between the cap-binding translation initiation factor (eIF4E) and eIF4G.
Ali IK; McKendrick L; Morley SJ; Jackson RJ
J Virol; 2001 Sep; 75(17):7854-63. PubMed ID: 11483729
[TBL] [Abstract][Full Text] [Related]
7. Structural insights into parasite eIF4E binding specificity for m7G and m2,2,7G mRNA caps.
Liu W; Zhao R; McFarland C; Kieft J; Niedzwiecka A; Jankowska-Anyszka M; Stepinski J; Darzynkiewicz E; Jones DN; Davis RE
J Biol Chem; 2009 Nov; 284(45):31336-49. PubMed ID: 19710013
[TBL] [Abstract][Full Text] [Related]
8. Triazole-containing monophosphate mRNA cap analogs as effective translation inhibitors.
Piecyk K; Lukaszewicz M; Darzynkiewicz E; Jankowska-Anyszka M
RNA; 2014 Oct; 20(10):1539-47. PubMed ID: 25150228
[TBL] [Abstract][Full Text] [Related]
9. eIF4E activity is regulated at multiple levels.
Raught B; Gingras AC
Int J Biochem Cell Biol; 1999 Jan; 31(1):43-57. PubMed ID: 10216943
[TBL] [Abstract][Full Text] [Related]
10. Exploring tryptamine conjugates as pronucleotides of phosphate-modified 7-methylguanine nucleotides targeting cap-dependent translation.
Golojuch S; Kopcial M; Strzelecka D; Kasprzyk R; Baran N; Sikorski PJ; Kowalska J; Jemielity J
Bioorg Med Chem; 2020 Jul; 28(13):115523. PubMed ID: 32362385
[TBL] [Abstract][Full Text] [Related]
11. Thermodynamic analysis of mRNA cap binding by the human initiation factor eIF4E via free energy perturbations.
Guimarães CR; Kopecky DJ; Mihalic J; Shen S; Jeffries S; Thibault ST; Chen X; Walker N; Cardozo M
J Am Chem Soc; 2009 Dec; 131(50):18139-46. PubMed ID: 19924990
[TBL] [Abstract][Full Text] [Related]
12. Design of nucleotide-mimetic and non-nucleotide inhibitors of the translation initiation factor eIF4E: Synthesis, structural and functional characterisation.
Soukarieh F; Nowicki MW; Bastide A; Pöyry T; Jones C; Dudek K; Patwardhan G; Meullenet F; Oldham NJ; Walkinshaw MD; Willis AE; Fischer PM
Eur J Med Chem; 2016 Nov; 124():200-217. PubMed ID: 27592390
[TBL] [Abstract][Full Text] [Related]
13. Contribution of trans-splicing, 5' -leader length, cap-poly(A) synergism, and initiation factors to nematode translation in an Ascaris suum embryo cell-free system.
Lall S; Friedman CC; Jankowska-Anyszka M; Stepinski J; Darzynkiewicz E; Davis RE
J Biol Chem; 2004 Oct; 279(44):45573-85. PubMed ID: 15322127
[TBL] [Abstract][Full Text] [Related]
14. Cell-penetrating HIV1 TAT peptides can generate pores in model membranes.
Ciobanasu C; Siebrasse JP; Kubitscheck U
Biophys J; 2010 Jul; 99(1):153-62. PubMed ID: 20655843
[TBL] [Abstract][Full Text] [Related]
15. eIF3d is an mRNA cap-binding protein that is required for specialized translation initiation.
Lee AS; Kranzusch PJ; Doudna JA; Cate JH
Nature; 2016 Aug; 536(7614):96-9. PubMed ID: 27462815
[TBL] [Abstract][Full Text] [Related]
16. Eukaryotic initiation factor 4E variants alter the morphology, proliferation, and colony-formation properties of MDA-MB-435 cancer cells.
Goldson TM; Vielhauer G; Staub E; Miller S; Shim H; Hagedorn CH
Mol Carcinog; 2007 Jan; 46(1):71-84. PubMed ID: 17091471
[TBL] [Abstract][Full Text] [Related]
17. Stabilization of eukaryotic initiation factor 4E binding to the mRNA 5'-Cap by domains of eIF4G.
von Der Haar T; Ball PD; McCarthy JE
J Biol Chem; 2000 Sep; 275(39):30551-5. PubMed ID: 10887196
[TBL] [Abstract][Full Text] [Related]
18. Stabilizing the eIF4G1 α-helix increases its binding affinity with eIF4E: implications for peptidomimetic design strategies.
Brown CJ; Lim JJ; Leonard T; Lim HC; Chia CS; Verma CS; Lane DP
J Mol Biol; 2011 Jan; 405(3):736-53. PubMed ID: 21094167
[TBL] [Abstract][Full Text] [Related]
19. Repressor binding to a dorsal regulatory site traps human eIF4E in a high cap-affinity state.
Ptushkina M; von der Haar T; Karim MM; Hughes JM; McCarthy JE
EMBO J; 1999 Jul; 18(14):4068-75. PubMed ID: 10406811
[TBL] [Abstract][Full Text] [Related]
20. Structural studies of the eIF4E-VPg complex reveal a direct competition for capped RNA: Implications for translation.
Coutinho de Oliveira L; Volpon L; Rahardjo AK; Osborne MJ; Culjkovic-Kraljacic B; Trahan C; Oeffinger M; Kwok BH; Borden KLB
Proc Natl Acad Sci U S A; 2019 Nov; 116(48):24056-24065. PubMed ID: 31712417
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
